INTEGRA LIFESCIENCES HOLDINGS CORP
IARTUS売上高
$1.6B
百万USD
営業利益
$-493M
百万USD
純利益
$-516M
百万USD
ROE
-49.5%
最新FY
EPS
$-6.74
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $360M | $45M | $0.53 |
| FY2021 | Q2 | $390M | $35M | $0.41 |
| FY2021 | Q3 | $387M | $43M | $0.51 |
| FY2021 | FY | $1.5B | $169M | $1.98 |
| FY2022 | Q1 | $377M | $33M | $0.39 |
| FY2022 | Q2 | $398M | $45M | $0.54 |
| FY2022 | Q3 | $385M | $50M | $0.60 |
| FY2022 | FY | $1.6B | $181M | $2.16 |
| FY2023 | Q1 | $381M | $24M | $0.29 |
| FY2023 | Q2 | $381M | $4M | $0.05 |
| FY2023 | Q3 | $382M | $19M | $0.24 |
| FY2023 | FY | $1.5B | $68M | $0.84 |
| FY2024 | Q1 | $369M | $-3M | $-0.04 |
| FY2024 | Q2 | $418M | $-12M | $-0.16 |
| FY2024 | Q3 | $381M | $-11M | $-0.14 |
| FY2024 | FY | $1.6B | $-7M | $-0.09 |
| FY2025 | Q1 | $383M | $-25M | $-0.33 |
| FY2025 | Q2 | $416M | $-484M | $-6.31 |
| FY2025 | Q3 | $402M | $-5M | $-0.07 |
| FY2025 | FY | $1.6B | $-516M | $-6.74 |
| FY2026 | Q1 | $392M | $-5M | $-0.06 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $1.5B | $1.5B | $1.4B | $1.5B | $1.6B | $1.5B | $1.6B | $1.6B |
| 営業利益 | $115M | $45M | $111M | $94M | $151M | $197M | $239M | $112M | $28M | $-493M |
| 純利益 | $75M | $65M | $61M | $50M | $134M | $169M | $181M | $68M | $-7M | $-516M |
| 総資産 | $1.8B | $3.2B | $3.1B | $3.3B | $3.6B | $3.8B | $3.9B | $3.8B | $4.0B | $3.6B |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $840M | $962M | $1.4B | $1.4B | $1.5B | $1.7B | $1.8B | $1.6B | $1.5B | $1.0B |
| 営業CF | $116M | $115M | $200M | $231M | $204M | $312M | $264M | $140M | $129M | $50M |
| EPS | $0.94 | $0.82 | $0.72 | $0.58 | $1.57 | $1.98 | $2.16 | $0.84 | $-0.09 | $-6.74 |
| BPS | $11.22 | $12.26 | $16.14 | $16.78 | $17.96 | $20.24 | $22.10 | $20.30 | $20.01 | $13.39 |
| ROE | 8.9% | 6.7% | 4.4% | 3.5% | 8.8% | 10.0% | 10.0% | 4.3% | -0.4% | -49.5% |